Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT00578188
Other study ID # IRB # 43921
Secondary ID ACH GL #039005
Status Withdrawn
Phase N/A
First received December 19, 2007
Last updated April 12, 2016
Start date February 2006
Est. completion date January 2008

Study information

Verified date April 2016
Source Arkansas Children's Hospital Research Institute
Contact n/a
Is FDA regulated No
Health authority United States: Federal Government
Study type Observational

Clinical Trial Summary

The purpose of this study is to determine if Chlamydial infections persist in the rectum of females who have had a sexually transmitted infection of Chlamydia.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 2008
Est. primary completion date January 2008
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 11 Years to 19 Years
Eligibility Inclusion Criteria:

- 11-19 years old

- Female

- Diagnosis of Chlamydia on enrollment visit

- Invitation to participate control group

Exclusion Criteria:

- Age out of range

- Negative Chlamydia screen (unless qualifies for control group)

- Unable to provide needed samples

Study Design

Observational Model: Case Control, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Arkansas Children's Hospital Little Rock Arkansas

Sponsors (1)

Lead Sponsor Collaborator
Arkansas Children's Hospital Research Institute

Country where clinical trial is conducted

United States, 

References & Publications (5)

Centers for Disease Control and Prevention (CDC). Chlamydia trachomatis genital infections--United States, 1995. MMWR Morb Mortal Wkly Rep. 1997 Mar 7;46(9):193-8. — View Citation

Cotter TW, Ramsey KH, Miranpuri GS, Poulsen CE, Byrne GI. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice. Infect Immun. 1997 Jun;65(6):2145-52. — View Citation

Dean D, Suchland RJ, Stamm WE. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J Infect Dis. 2000 Sep;182(3):909-16. Epub 2000 Aug 17. — View Citation

Igietseme JU, Portis JL, Perry LL. Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae. Infect Immun. 2001 Mar;69(3):1832-40. — View Citation

Jones RB, Rabinovitch RA, Katz BP, Batteiger BE, Quinn TS, Terho P, Lapworth MA. Chlamydia trachomatis in the pharynx and rectum of heterosexual patients at risk for genital infection. Ann Intern Med. 1985 Jun;102(6):757-62. — View Citation

See also
  Status Clinical Trial Phase
Terminated NCT00091728 - Hormonal Contraception and Risk of Chlamydia and Gonorrhea Phase 4
Completed NCT00207493 - The Participant Agreement for Contact Tracing (PACT) Study: Enhancing Partner Notification Services. Phase 1/Phase 2
Terminated NCT01291264 - Use of Abbott RealTime CT/NG to Detect Chlamydia Trachomatis [CT] & Neisseria Gonorrhoeae [NG] in Men Who Have Sex With Men [MSM] Phase 4